# ResMed (RMD) — Analyst Forecast

RMD · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/rmd/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 15, 2026 | RBC Capital | Upgraded | Sector Perform → Outperform | $262.00 |
| Aug 31, 2026 | Keybanc | Maintained | Overweight | $267.00 |
| Aug 19, 2026 | Rothschild & Co | Initiated Coverage | Neutral | $230.00 |
| Aug 7, 2026 | Keybanc | Maintained | Overweight | $255.00 |
| Aug 7, 2026 | Wells Fargo | Maintained | Equal-Weight | $215.00 |
| Aug 7, 2026 | Piper Sandler | Maintained | Neutral | $225.00 |
| Aug 7, 2026 | RBC Capital | Maintained | Sector Perform | $244.00 |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | $220.00 |
| Jul 13, 2026 | Citigroup | Downgraded | Buy → Neutral | $235.00 |
| Jul 10, 2026 | Jefferies | Maintained | Hold | $225.00 |
| Jul 8, 2026 | Wells Fargo | Maintained | Equal-Weight | $225.00 |
| Jul 8, 2026 | RBC Capital | Maintained | Outperform | $276.00 |
| Jun 22, 2026 | Keybanc | Maintained | Overweight | $266.00 |
| Jun 17, 2026 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $230.00 |
| Jun 15, 2026 | Citigroup | Maintained | Buy | $270.00 |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | $227.00 |
| May 1, 2026 | RBC Capital | Maintained | Outperform | $321.00 |
| Apr 27, 2026 | Keybanc | Maintained | Overweight | $290.00 |
| Apr 15, 2026 | JP Morgan | Maintained | Overweight | — |
| Apr 9, 2026 | Citigroup | Maintained | Buy | $340.00 |

## Frequently Asked Questions

### What is the latest analyst rating on RMD?

On Sep 15, 2026, RBC Capital upgraded ResMed to Outperform with a price target of $262.00.

## Similar Stocks

- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [HIMS](https://www.lighthorse.io/tickers/hims) — Hims & Hers Health, Inc. Class A Common Stock
- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).